A two-sample Mendelian randomization study to identity microbiome signatures in patients with Non-alcoholic fatty liver disease

Dig Liver Dis. 2023 Nov;55(11):1462-1463. doi: 10.1016/j.dld.2023.07.029. Epub 2023 Aug 1.

Authors

Roberta Forlano¹, Giordano Sigon²

Affiliations

¹ Liver and anti-viral unit, Division of Digestive Diseases, Department of Metabolism, Digestion and Reproduction, Imperial college London, London, United Kingdom. Electronic address: r.forlano@imperial.ac.uk.
² Liver and anti-viral unit, Division of Digestive Diseases, Department of Metabolism, Digestion and Reproduction, Imperial college London, London, United Kingdom; University of Milan, Milan, Italy.

PMID: 37537013
DOI: 10.1016/j.dld.2023.07.029

No abstract available

Publication types

Comment

MeSH terms

Humans
Mendelian Randomization Analysis
Non-alcoholic Fatty Liver Disease* / genetics
Polymorphism, Single Nucleotide